Skip to content

Author

Joseph Kauer

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Impact of daratumumab on stem cell collection in patients with AL amyloidosis

Autologous stem cell transplantation following high-dose melphalan is an effective consolidation therapy for the initial treatment of systemic AL amyloidosis. While quadruplet induction therapy involving daratumumab is the standard-of-care, its impact on stem cell yield has not been studied. Furthermore, the rela...

Joseph Kauer, Tobias Dittrich, Andreas Smeykal et al. · 0 citations
Open access Sep 2026

Loncastuximab tesirine in heavily pretreated patients with large B-cell lymphoma: a German Lymphoma Alliance analysis.

For patients with large B-cell lymphoma progressing after multiple lines of therapy few treatment options remain, including the new CD19-directed antibody-drug conjugate loncastuximab tesirine (lonca). To further elucidate its efficacy and safety, we conducted a real-world analysis including data from 31 German centers...

Evgenii Shumilov, Lina J. Kolloch, Philipp Faustmann et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.